newsfilter
← Latest News
Business Wire·

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

- Responds to Substantial Stock Accumulation by Anson Advisors and Cable Car Capital - - Protects Long-Term Value of All Stockholders' Investments in MEI Pharma - MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage